Abstract | BACKGROUND: METHODS: In a nested case-cohort study (135 GDM cases and 517 non-GDM controls), we measured maternal serum vitamin D status (total 25[ OH]D and 25[ OH]D3 ) in early pregnancy (16 weeks on average) using liquid chromatography-tandem mass spectroscopy. GDM was diagnosed according to the American Diabetes Association guidelines. We calculated adjusted odds ratios and 95% confidence intervals (CIs) using logistic regression models. RESULTS: GDM cases had lower mean total 25[ OH]D (27.3 vs. 29.3 ng/mL) and 25[ OH]D3 (23.9 vs. 26.7 ng/mL) concentrations compared with women who did not develop GDM (both P-values < 0.05). Overall, 25[ OH]D3 concentrations, but not total 25[ OH]D concentrations, were significantly associated with GDM risk. A 5-ng/mL increase in 25[ OH]D3 concentration was associated with a 14% decrease in GDM risk (P-value = 0.02). Women in the lowest quartile for 25[ OH]D3 concentration had a twofold [95% CI 1.15, 3.58] higher risk of GDM compared with women in the highest quartile (P-value for trend < 0.05). CONCLUSIONS: Early pregnancy vitamin D status, particularly 25[ OH]D3 , is inversely associated with GDM risk.
|
Authors | Dodie L Arnold, Daniel A Enquobahrie, Chungfang Qiu, Jonathan Huang, Nancy Grote, Ann VanderStoep, Michelle A Williams |
Journal | Paediatric and perinatal epidemiology
(Paediatr Perinat Epidemiol)
Vol. 29
Issue 3
Pg. 200-10
(May 2015)
ISSN: 1365-3016 [Electronic] England |
PMID | 25808081
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
|
Copyright | © 2015 John Wiley & Sons Ltd. |
Chemical References |
- Vitamins
- Vitamin D
- 25-hydroxyvitamin D
|
Topics |
- Diabetes, Gestational
(drug therapy, etiology, prevention & control)
- Female
- Humans
- Pregnancy
- Pregnant Women
- Prospective Studies
- Vitamin D
(analogs & derivatives, blood, therapeutic use)
- Vitamin D Deficiency
(blood, complications, drug therapy)
- Vitamins
(blood, therapeutic use)
|